Search
for
Sort by
Research 121–150 of 284
- Bioavailability File: Bicalutamide
- Hormonal Influences on Women's Health and Athletic Performance: Insights into the Menstrual Cycle, Menopause, Contraception, and Anabolic Steroids
- If Women Just had Their Hormones Back the Way they Were!
- If women just had their hormones back the way they were! (for youthful feeling-balance your hormones!)
- Effect of decellularisation methods on methacryloyl-substituted placental ECM hydrogels
- Inherited Epidermolysis Bullosa: A Clinical Case
- Program and Abstract of 16th APALMS 2018
- Prostate cancer and androgenic alopecia
- The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
- Cutaneous complications of chemotherapeutic agents
- Association of Suicidality and Depression With 5α-Reductase Inhibitors
- Polycystic Ovary Syndrome
- Cutaneous manifestations of HIV infection other than Kaposi's sarcoma: Clinical and histologic aspects
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Baldness, acne and testicular germ cell tumours
- Iron deficiency and diffuse nonscarring scalp alopecia in women: More pieces to the puzzle
- Expanding the Clinical and Mutational Spectrum of Recessive AEBP1-Related Classical-Like Ehlers-Danlos Syndrome
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- A machine learning and network framework to discover new indications for small molecules
- Prostate cancer update: 2007
- Psychiatry, Medicine
- Dictionary
- Health Messages
- Risks and side effects in the medical management of benign prostatic hyperplasia
- 69-Year-Old Man With Nasal Congestion and Pre-Syncope
- Table_2.docx
- Table_1.docx
- The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs).
- Identification of a novel homozygous LAMB3 mutation in a Chinese male with junctional epidermolysis bullosa and severe urethra stenosis: A case report
- SAT-213 Late Diagnosis of Complete Androgen Insensitivity